Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Biliary Tract Neoplasms × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 37 Neoplasms 6 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Adenocarcinoma 3 Resectable Pancreatic Cancer 2 Rectal Neoplasms 2 Pancreatic Cancer Metastatic 2 Carcinoma, Hepatocellular 2 Urachal cancer 1 Stomach Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Pancreatic Adenocarcinoma 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Localized Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Islet Cell 1 Carcinoma 1 Borderline Resectable Pancreatic Cancer 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 79 Cisplatin 63 Capecitabine 33 Oxaliplatin 30 durvalumab 29 pembrolizumab 22 Fluorouracil 22 Leucovorin 21 S 1 (combination) 15 lenvatinib 11 Nivolumab 11 Irinotecan 11 tremelimumab 10 Bevacizumab 9 Injections 7 130-nm albumin-bound paclitaxel 7 apatinib 6 Trastuzumab 6 Docetaxel 6 titanium silicide 5 surufatinib 5 camrelizumab 5 Immune Checkpoint Inhibitors 5 Drug Therapy 5 Carboplatin 5 Albumin-Bound Paclitaxel 5 zanidatamab 4 irinotecan sucrosofate 4 gemcitabine-oxaliplatin regimen 4 envafolimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03291899 2024-01-17

FBI-TRAC

King Faisal Specialist Hospital & Research Center

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡